| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9347650 | Ophthalmology | 2005 | 5 Pages |
Abstract
Therapy of chronic dry eye disease with cyclosporine 0.1% ophthalmic emulsion for 1 to 3 years was safe, well tolerated, and not associated with systemic side effects. The results supplement the safety record of the commercially available cyclosporine 0.05% ophthalmic emulsion.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Laurie D. MD, Stephen C. MD, Joseph MD, Gary N. MD,